EXAS

EXAS

USD

Exact Sciences Corporation Common Stock

$69.590-0.480 (-0.685%)

リアルタイム価格

Healthcare
Diagnostics & Research
米国

価格チャート

Loading Chart...

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$70.070

高値

$72.810

安値

$67.970

出来高

1.54M

企業ファンダメンタルズ

時価総額

13.2B

業種

Diagnostics & Research

United States

取引統計

平均出来高

2.95M

取引所

NCM

通貨

USD

52週レンジ

安値 $38.81現在値 $69.590高値 $72.83

関連ニュース

Analyst Upgrades

TD Cowen Maintains Buy on Exact Sciences, Raises Price Target to $90

TD Cowen analyst Dan Brennan maintains Exact Sciences with a Buy and raises the price target from $74 to $90.

もっと見る
TD Cowen Maintains Buy on Exact Sciences, Raises Price Target to $90
Analyst Upgrades

Baird Maintains Outperform on Exact Sciences, Raises Price Target to $88

Baird analyst Catherine Schulte maintains Exact Sciences with a Outperform and raises the price target from $72 to $88.

もっと見る
Baird Maintains Outperform on Exact Sciences, Raises Price Target to $88
Analyst Upgrades

Benchmark Maintains Buy on Exact Sciences, Raises Price Target to $75

Benchmark analyst Bruce D. Jackson maintains Exact Sciences with a Buy and raises the price target from $60 to $75.

もっと見る
Benchmark Maintains Buy on Exact Sciences, Raises Price Target to $75
Analyst Upgrades

Guggenheim Maintains Buy on Exact Sciences, Raises Price Target to $75

Guggenheim analyst Subbu Nambi maintains Exact Sciences with a Buy and raises the price target from $70 to $75.

もっと見る
Guggenheim Maintains Buy on Exact Sciences, Raises Price Target to $75
Analyst Upgrades

Barclays Maintains Overweight on Exact Sciences, Raises Price Target to $77

Barclays analyst Luke Sergott maintains Exact Sciences with a Overweight and raises the price target from $65 to $77.

もっと見る
Barclays Maintains Overweight on Exact Sciences, Raises Price Target to $77
Analyst Upgrades

Stifel Maintains Buy on Exact Sciences, Raises Price Target to $80

Stifel analyst Daniel Arias maintains Exact Sciences with a Buy and raises the price target from $67 to $80.

BusinessWire

Exact Sciences to Participate in November Investor Conference

Exact Sciences Corp. (NASDAQ:EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conference and invited investors to participate